Selah Genomics is a personalized medicine diagnostic specialist supporting healthcare providers and the pharmaceutical industry with advanced molecular and genomic diagnostic services. Selah delivers a rapidly growing portfolio of advanced diagnostic tests, focused initially towards oncology and infectious disease. Selah’s services add value to early stage drug development, clinical trials and regulatory processes in the pharmaceutical industry and helps clinicians and healthcare providers treat and monitor patients, thereby improving patient outcomes.